US Patent 11175293 Rapid assay for detection of SARS-CoV-2 antibodies
Patent 11175293 was granted and assigned to University of Utah on November, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+237 characters)
Article
Patent abstract
Described herein are diagnostic and control fusion protein reagents and methods for use thereof in simple rapid and inexpensive hemagglutinin assays for the detection of subject antibodies directed to the SARS-CoV-2 virus.
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 26 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
111752930
Date of Patent
November 16, 2021
0Patent Application Number
171403210
Date Filed
January 4, 2021
0Official Website
Patent Primary Examiner
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
111752930
Date of Patent
November 16, 2021
0Patent Application Number
171403210
Date Filed
January 4, 2021
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 19 Nov, 2021
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 11175293 Rapid assay for detection of SARS-CoV-2 antibodies
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11175293
Date of patent
November 16, 2021
Patent application number
17140321
Date Filed
January 4, 2021
Patent primary examiner
Find more entities like US Patent 11175293 Rapid assay for detection of SARS-CoV-2 antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
